← Browse by Condition
Medical Condition

scleroderma diffuse

Total Trials
1
Recruiting Now
1
Trial Phases
Phase 2
NCT06655896 Phase 2
Recruiting

Phase 2 Study Evaluating Rapcabtagene Autoleucel in Participants With Diffuse Cutaneous Systemic Sclerosis

Enrollment
96 pts
Location
United States, Austr...
Sponsor
Novartis Pharmaceuticals
View Trial →